Unlocking the Secrets of DNA Repair
News Nov 02, 2012
Groundbreaking research led by Dr David Williams from the University of Sheffield's Department of Chemistry and an international collaboration of expert researchers has discovered how some proteins recognise damaged bases within DNA which, if untreated, could lead to cancer.
Dr Williams said: "Proteins carry out all the day-to-day processes needed for survival. If the DNA bases become damaged the associated protein may not function or in some cases, too much of a certain protein can be produced – which might lead to cancer.
"Everyday humans are exposed to chemicals known as alkylating agents which may be derived from environmental sources or from dietary sources such as a high intake of red or processed meat or exposure to tobacco smoke. Alkylating agents can chemically modify the bases in DNA which can, in turn, lead to non-functional proteins being produced or indeed cancer.
"Fortunately humans have a large number of different DNA repair proteins whose task it is to find and repair damaged bases in DNA. However DNA base damage, although highly problematic, is rare and often only one or two bases per million or even fewer. The task of locating a damaged base is similar to finding a needle in a haystack."
DNA contains all the information needed for life within the sequence of its four bases; adenine, cytosine, guanine and thymine. Specific sequences of bases in DNA known as genes instruct what proteins are made and furthermore genes may be switched on or off to control how much of each protein is made.
The pioneering research, published in the journal: Proceeding of the National Academy of Sciences of the United States of America (PNAS), was conducted by scientists from the University of Sheffield, University of Manchester and the Scripps Research Institute in California and focuses on damage to the guanine base to form O6-alkylguanine, a type of damage that is particularly prevalent in colon or bowel cancer.
"In humans this is repaired by alkyltransferase proteins that simply reverse the damage of these modified bases, converting them back to guanine," said Dr Williams.
"We have uncovered an exquisite mechanism whereby a positively charged side chain of the amino acid arginine found in the Alt1 protein is used to check the electronic charge distribution across the DNA base, which is altered by alkylation damage.
"This method of recognition, we believe, may also be used by many other DNA repair proteins to recognise damaged bases within DNA. A further exciting discovery we have made is to show that the alkyltransferase-like protein Alt1 can detect all known types of O-alkylguanine modification.
"Consequently, Alt1 has potential for use in identifying and quantifying levels of certain O6- alkylguanines in human tissue biopsies. This would be informative to clinicians about individual susceptibility to certain cancers, particularly colorectal."
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE
Antarctic Worm and Machine Learning Help Identify Cerebral Palsy EarlierNews
A research team has released a study in the peer-reviewed journal BMC Bioinformatics showing that DNA methylation patterns in circulating blood cells can be used to help identify spastic cerebral palsy (CP) patients. The technique which makes use of machine learning, data science and even analysis of Antarctic worms, raises hopes for earlier targeted CP therapies.